Worth reading
60In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
542600
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status of the 11th Series Stock Acquisition Rights issued through a third-party allotment (with clauses for adjustment of the exercise price and suspension of exercise)
発行・処分する株式数
Number of shares delivered during the month: 542,600 shares (542,600 new shares and 0 transferred treasury shares)
Intended allottee
EVO FUND (allottee of the previously issued stock acquisition rights)
発行済株式総数
Exercise ratio subject to exercise restrictions: 3.6% (542,600 shares / 14,942,292 shares)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise prices during the month: ¥301, ¥278, ¥269, ¥268, ¥267, ¥255 and ¥254. Subject to a clause for adjustment of the exercise price. The adjustment floor is not disclosed.
Number of Stock Acquisition Rights
Total issued: 104,596 rights. Unexercised rights as of the end of the month preceding the subject month: 101,226. Unexercised rights as of the end of the subject month: 95,800. Rights exercised during the month: 5,426.
Procedures under the Corporate Code of Conduct
Describes compliance with the exercise restrictions under Article 434 of the Listing Regulations. Whether an independent third-party opinion was obtained or shareholder approval was confirmed is not disclosed.
Most recent equity financing
12 February 2026: Issuance through a third-party allotment of the 11th Series Stock Acquisition Rights (with clauses for adjustment of the exercise price and suspension of exercise) (see the materials announced on 27 January 2026 for details)
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of the 11th Series Stock Acquisition Rights issued through a third-party allotment (with clauses for adjustment of the exercise price and suspension of exercise) |
| Number of shares to be issued or disposed of | Number of shares delivered during the month: 542,600 shares (542,600 new shares and 0 transferred treasury shares) |
| Intended allottee | EVO FUND (allottee of the previously issued stock acquisition rights) |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 3.6% (542,600 shares / 14,942,292 shares) |
| Total number of issued shares | 15,279,292 shares (as of the end of the month preceding the subject month, including 203,957 treasury shares) → Not disclosed |
| Exercise price | Exercise prices during the month: ¥301, ¥278, ¥269, ¥268, ¥267, ¥255 and ¥254. Subject to a clause for adjustment of the exercise price. The adjustment floor is not disclosed. |
| Number of Stock Acquisition Rights | Total issued: 104,596 rights. Unexercised rights as of the end of the month preceding the subject month: 101,226. Unexercised rights as of the end of the subject month: 95,800. Rights exercised during the month: 5,426. |
| Procedures under the Corporate Code of Conduct | Describes compliance with the exercise restrictions under Article 434 of the Listing Regulations. Whether an independent third-party opinion was obtained or shareholder approval was confirmed is not disclosed. |
| Most recent equity financing | 12 February 2026: Issuance through a third-party allotment of the 11th Series Stock Acquisition Rights (with clauses for adjustment of the exercise price and suspension of exercise) (see the materials announced on 27 January 2026 for details) |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status and compliance with exercise restrictions.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.